P-6292

Haematologica | 2026

Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in Acute Myeloid Leukemia in first complete remission: CIBMTR analysis.

Tettero JM, Zhang MJ, Liu W, Nawas MT, Milano F, Bejanyan N, Bachanova V, Broglie L, Saber W, Gui G, Dillon LW, Walter RB, Page KM, Hourigan CS, El Chaer F

PubMed
PMID: 42206435

Abstract
Related Articles

CIBMTR Study #: LK21-01g